Earnings Call · Q1 FY2022·2022-05-07

Q1 22EPS -50.00%·Rev n/aQ4 21EPS -61.54%·Rev n/aQ3 21EPS -25.00%·Rev n/aQ2 21EPS -100.00%*·Rev n/a⚠ consensus missing

Cytosorbents Corp CTSO

Terri Anne Powers — Investor Relations

Phillip Chan — Chief Executive Officer

Vincent Capponi — President and Chief Operating Officer

Kathleen Bloch — Chief Financial Officer

Christian Steiner — Chief Commercial Officer

Christopher Cramer — Role not explicitly stated

Efthymios Deliargyris — Chief Medical Officer

−2.8%1d on move date−5.8% vs SPY3d−14.7%5d−5.0%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CTSO calls or request research access.

More CTSO calls Browse calls Request research access